A primary signet ring cell carcinoma of the prostate with bone metastasis with impressive response to FOLFOX and Cetuximab

Simple item page
UDC.coleccionInvestigaciónes_ES
UDC.departamentoFisioterapia, Medicina e Ciencias Biomédicases_ES
UDC.endPage201es_ES
UDC.grupoInvGrupo Fisiopatoloxía Endócrina, Nutricional e Médica (FENM)es_ES
UDC.issue3es_ES
UDC.journalTitleClinical Geritourinary Canceres_ES
UDC.startPage199es_ES
UDC.volume10es_ES
dc.contributor.authorRoldán, Ana Milena
dc.contributor.authorFernández-Núñez, Natalia
dc.contributor.authorGrande, Enrique
dc.contributor.authorÁlvarez García, Augusto
dc.contributor.authorAntón-Aparicio, Luis M.
dc.date.accessioned2018-01-15T08:48:29Z
dc.date.available2018-01-15T08:48:29Z
dc.date.issued2012-03-10
dc.identifier.citationRoldán AM, Fernández-Núñez N, Grande E, Álvarez-García A, Antón-Aparicio LM. A primary signet ring cell carcinoma of the prostate with bone metastasis with impressive response to FOLFOX and Cetuximab. Clin Geritorin Cancer. 2012;10(3):199-201es_ES
dc.identifier.issn1558-7673
dc.identifier.issn1938-0682
dc.identifier.urihttp://hdl.handle.net/2183/19984
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.relation.urihttp://dx.doi.org/10.1016/j.clgc.2012.01.006es_ES
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Españaes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectAdenocarcinomaes_ES
dc.subjectCetuximabes_ES
dc.subjectProstatees_ES
dc.subjectSignet ring celles_ES
dc.titleA primary signet ring cell carcinoma of the prostate with bone metastasis with impressive response to FOLFOX and Cetuximabes_ES
dc.typejournal articlees_ES
dspace.entity.typePublication
relation.isAuthorOfPublication540d4e02-eace-4748-805e-aebc330ae83c
relation.isAuthorOfPublication.latestForDiscovery540d4e02-eace-4748-805e-aebc330ae83c

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Mlna_Primary.pdf
Size:
180.53 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Investigación (FCS)